Literature DB >> 4404857

Presence of red cell type NADH-methemoglobin reductase (NADH-diaphorase) in human non erythroid cells.

A Leroux, J C Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404857     DOI: 10.1016/0006-291x(72)90303-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase.

Authors:  J C Kaplan
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

3.  Assignment of NADH-cytochrome b5 reductase (DIA1 locus) to human chromosome 22.

Authors:  C Junien; M Vibert; D Weil; N Van-Cong; J C Kaplan
Journal:  Hum Genet       Date:  1978-06-27       Impact factor: 4.132

4.  Importance of oxidative metabolism in T cell cytotoxicity: a comparison of cloned T cells and spleen cells.

Authors:  K J Thorne; D Franks
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

5.  Human FAD-dependent NAD(P)H diaphorase.

Authors:  Y H Edwards; J Potter; D A Hopkinson
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

6.  NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Authors:  D Lostanlen; G Lenoir; J C Kaplan
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

7.  Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation.

Authors:  M Takeshita; T Matsuki; K Tanishima; T Yubisui; Y Yoneyama; K Kurata; N Hara; T Igarashi
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.